Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients.

In the setting of rCDI, the transmission of Blastocystis ST1 and ST3 via FMT did not result in a significant decrease in the efficacy of FMT, although there was a nonsignificant trend towards an increased rate of CDI events (both relapses and new episodes) in patients treated with Blastocystis sp.–positive donors (8/31) versus Blastocystis sp.–negative donors (12/82).

also in 5,406 other papers